Search
for
Sort by
Research 91–120 of 219
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Where it all went right
- A systematic review on Drug Re-profiling/Re-Purposing
- Men??s Health
- Medication Repurposing: New Uses for Old Drugs
- Developmental and functional roles of androgen and interactive signals for external genitalia and erectile tissues
- Spotlight Commentary: Importance of dose redefining in the process of drug repurposing
- Why Do Promising Therapies Stall in Development and How Can We Move Them Forward?
- Drug Repurposing: Expanding Therapeutic Potential of Existing Drugs
- Redefining Drug Discovery: A Review of Drug Repurposing –Approaches, Benefits and Breakthroughs
- Repurposed Drugs: Current Trends in Drug Discovery
- Off Label Medication and Use of Unapproved Drugs
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Network-Based Drug Repositioning: Approaches, Resources, and Research Directions
- Drug repositioning using <i>in silico</i> compound profiling
- Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto
- Finasteride
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- The PDGF/PDGFR pathway as a drug target
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- A review of the treatment of male pattern hair loss
- Bimatoprost in the treatment of eyelash universalis alopecia areata
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia